Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,761 to 1,780 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barré syndrome. | Cell Prolif | 2021 | 33751722 | PubTator, text mining | PubMed |
| Investigating the Internalization and COVID-19 Antiviral Computational Analysis of Optimized Nanoscale Zinc Oxide. | ACS Omega | 2021 | 33748599 | PubTator, text mining | PubMed |
| SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan. | ACS Omega | 2021 | 33748571 | PubTator, text mining | PubMed |
| Structural and molecular perspectives of SARS-CoV-2. | Methods | 2021 | 33737214 | PubTator, text mining | PubMed |
| Global and local mutations in Bangladeshi SARS-CoV-2 genomes. | Virus Res | 2021 | 33737154 | PubTator, text mining | PubMed |
| Genomic surveillance of SARS-CoV-2 in the Republic of Congo. | Int J Infect Dis | 2021 | 33737129 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing. | PLoS One | 2021 | 33735271 | PubTator, text mining | PubMed |
| Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19. | Front Immunol | 2021 | 33732261 | PubTator, text mining | PubMed |
| A review on the phytochemical and pharmacological properties of Hyptis suaveolens (L.) Poit. | Futur J Pharm Sci | 2021 | 33728353 | PubTator, text mining | PubMed |
| Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus. | Microb Pathog | 2021 | 33727169 | PubTator, text mining | PubMed |
| Human coronaviruses and therapeutic drug discovery. | Infect Dis Poverty | 2021 | 33726861 | PubTator, text mining | PubMed |
| Membrane remodeling by SARS-CoV-2 - double-enveloped viral replication. | Fac Rev | 2021 | 33718934 | PubTator, text mining | PubMed |
| The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection. | Front Pharmacol | 2021 | 33716745 | PubTator, text mining | PubMed |
In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. | Front Pharmacol | 2021 | 33716737 | PubTator, text mining | PubMed |
| Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML. | Sci Rep | 2021 | 33712646 | PubTator, text mining | PubMed |
| A novel cell culture system modeling the SARS-CoV-2 life cycle. | PLoS Pathog | 2021 | 33711082 | PubTator, text mining | PubMed |
| Crystallographic models of SARS-CoV-2 3CLpro: in-depth assessment of structure quality and validation. | IUCrJ | 2021 | 33708401 | PubTator, text mining | PubMed |
| Clinical and molecular aspects of veterinary coronaviruses. | Virus Res | 2021 | 33705799 | PubTator, text mining | PubMed |
| Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation. | Heliyon | 2021 | 33693066 | PubTator, text mining | PubMed |
| Understanding COVID-19 in Wuhan From the Perspective of Cold-Dampness: Clinical Evidences and Mechanisms. | Front Med (Lausanne) | 2021 | 33693014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=89